Book description
Returning from Death Benefit, embattled medical student Pia Grazdani
decides to take a year off from her studies and escape New York City.
Intrigued by the promise of the burgeoning field of medical technology,
Pia takes a job at Nano, LLC, a lavishly funded, security-conscious
nanotechnology institute in the picturesque foothills of the Rocky
Mountains in Colorado. Nano, LLC is ahead of the curve in the
competitive world of molecular manufacturing, including the construction
of microbivores, tiny nano-robots with the ability to gobble up viruses
and bacteria. But the corporate campus is a place of secrets. When Pia
encounters a fellow employee on a corporate jogging path suffering the
effects of a seizure, she soon realizes she may have literally stumbled
upon one of Nano, LLC's human guinea pigs. Is the tech giant on the cusp
of one of the biggest medical discoveries of the twenty-first century -
a treatment option for millions - or have they already sold out to the
highest bidder? Doctor and author Robin Cook is widely credited with
introducing the word 'medical' to the thriller genre, and over twenty
years after the publication of his breakthrough novel, Coma, he
continues to dominate the category he created. Cook has successfully
combined medical fact with fiction to produce over twenty-seven
international bestsellers, including Outbreak (1987), Terminal (1993),
Contagion (1996), Chromosome 6 (1997), Foreign Body (2008), Intervention
(2010) and most recently Cure (2011).
